Osteoprotegerin inhibits aortic valve calcification and preserves valve function in hypercholesterolemic mice
about
Conserved transcriptional regulatory mechanisms in aortic valve development and diseaseAdvances in the treatment of aortic valve disease: is it time for companion diagnostics?Innate and Adaptive Immunity in Calcific Aortic Valve DiseasePioglitazone attenuates valvular calcification induced by hypercholesterolemia.Denosumab could be a Potential Inhibitor of Valvular Interstitial Cells Calcification in vitro.NOTCH1 Mutations in Aortic Stenosis: Association with Osteoprotegerin/RANK/RANKL.Review of molecular and mechanical interactions in the aortic valve and aorta: implications for the shared pathogenesis of aortic valve disease and aortopathy.Targeting local vascular and systemic consequences of inflammation on vascular and cardiac valve calcification.Human interstitial cellular model in therapeutics of heart valve calcification.A biomarker, osteoprotegerin, in patients undergoing hemodialysis.RANKL system in vascular and valve calcification with aging.Cellular Mechanisms of Aortic Valve Calcification.The role of TNF-α and TNF superfamily members in the pathogenesis of calcific aortic valvular disease.The Role of Osteoprotegerin as a Cardioprotective Versus Reactive Inflammatory Marker: the Chicken or the Egg Paradox
P2860
Q27014023-A2815131-FEF6-4102-9FC4-3CF500529B67Q34251241-486CDF8C-57A2-4A03-B579-ED31B0FBE29DQ35612638-2BBE3ED9-E5D5-43B2-A9A6-CCEF768A484FQ36612212-CA98BC19-E4F6-400F-A030-387731AA4343Q37123162-62221720-459E-46BE-A479-DC42FDF8E62FQ37633121-1890031C-2296-43CB-8846-9CAEA695FD01Q38269616-37DA5B1D-AE64-401C-9800-D7D393D9FC39Q38703771-4B549FF9-DB2F-4903-AB7E-2775084494A6Q39325703-2DF3D9C2-3DB5-428B-9805-379FD6EFCD7EQ42854913-BFC7B9D1-7822-45A2-8405-FB6ECB9FF455Q47671473-1BE318DA-CC6C-4AA6-84B0-BA9071A0AF92Q50142021-78990154-3957-451F-9C7E-3328C8C9CCD8Q54487255-0A98F394-CC18-4E14-9163-469B986DAFCCQ55285084-E3C52C16-B889-4242-BAF0-37787DC44F88
P2860
Osteoprotegerin inhibits aortic valve calcification and preserves valve function in hypercholesterolemic mice
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Osteoprotegerin inhibits aorti ...... n in hypercholesterolemic mice
@ast
Osteoprotegerin inhibits aorti ...... n in hypercholesterolemic mice
@en
Osteoprotegerin inhibits aorti ...... n in hypercholesterolemic mice
@nl
type
label
Osteoprotegerin inhibits aorti ...... n in hypercholesterolemic mice
@ast
Osteoprotegerin inhibits aorti ...... n in hypercholesterolemic mice
@en
Osteoprotegerin inhibits aorti ...... n in hypercholesterolemic mice
@nl
prefLabel
Osteoprotegerin inhibits aorti ...... n in hypercholesterolemic mice
@ast
Osteoprotegerin inhibits aorti ...... n in hypercholesterolemic mice
@en
Osteoprotegerin inhibits aorti ...... n in hypercholesterolemic mice
@nl
P2093
P2860
P1433
P1476
Osteoprotegerin inhibits aorti ...... n in hypercholesterolemic mice
@en
P2093
Donald D Heistad
Donald D Lund
Georges P Hajj
Kathy A Zimmerman
M Bridget Zimmerman
Melissa K Davis
Robert M Brooks
Robert M Weiss
P2860
P304
P356
10.1371/JOURNAL.PONE.0065201
P407
P577
2013-06-06T00:00:00Z